Green Cross Holdings Corporation (KRX:005250)

South Korea flag South Korea · Delayed Price · Currency is KRW
15,570
-100 (-0.64%)
Last updated: Aug 13, 2025
-8.09%
Market Cap 708.72B
Revenue (ttm) 2.23T
Net Income (ttm) 67.20B
Shares Out 45.40M
EPS (ttm) 1,480.06
PE Ratio 10.55
Forward PE n/a
Dividend 500.00 (3.19%)
Ex-Dividend Date Dec 27, 2024
Volume 6,516
Average Volume 63,270
Open 15,570
Previous Close 15,670
Day's Range 15,550 - 15,690
52-Week Range 12,000 - 18,490
Beta 1.11
RSI 42.09
Earnings Date Aug 14, 2025

About Green Cross Holdings

Green Cross Holdings Corporation operates as a biotechnology company. The company provides prescription drugs and over the counter drugs; aseptic fill and finish services for drug manufacturing; and pharmaceutical logistics services. It also researches and develops plasma derivatives for von Willebrand disease and primary immunodeficiency; vaccines for mRNA flu, anthrax, tetanus, diphtheria, pertussis, tuberculosis, and varicella; recombinant treatments for acquired thrombotic thrombocytopenic purpura, fabry, hemophilia, hunterase, colon cancer... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1967
Employees 141
Stock Exchange Korea Stock Exchange
Ticker Symbol 005250
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.